On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Kimberly Kline is a Professor in the Department of Microbiology and Molecular Medicine at the University of Geneva in Switzerland. From 2011-2022, she was a Professor in the School of Biological Sciences at NTU Singapore and a Principal Investigator at SCELSE. Kimberly received a Master’s in Public Health and a PhD in Microbiology and Immunology from Northwestern University where she studied Type IV pilus antigenic variation in Neisseria gonorrhoeae. She completed postdoctoral training at Washington University in St. Louis and at the Karolinska Institute in Stockholm Sweden where she began investigating the pathogenic mechanisms of Enterococcus faecalis. Kimberly has received multiple awards for her contributions to the field of microbiology, including a NIH K99 Career Development Award in 2011, the Singapore National Research Foundation Fellowship in 2011, the ICAAC Young Investigator Award from the American Society of Microbiology in 2014, the Nanyang Education Award in 2017, and election to the American Academy of Microbiology in 2025. Current research interests of her group include the pathogenic mechanisms of polymicrobial biofilm-associated infections, including catheter-associated urinary tract infections, wound infections, and infective endocarditis. Given the intrinsic phenotypic resistance of biofilms to antimicrobials, her team seeks to exploit their fundamental discoveries to identify new therapeutic intervention points for these difficult-to-treat infections.